Evidence map›Paper›PMID 42688067›Full record

ArticleFrontiers in oncology2026

Further assessment of structural and social determinant of health effects on breast cancer care timelines: a qualitative study.

Danielle Tomer, Sara Friedman, Risha Sheni, Dana Watnick, Della Makower, Anjuli M Gupta, Sheldon Feldman, Maureen McEvoy, Vikas Mehta

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Danielle TomerAlbert Einstein College of Medicine, Bronx, NY, United States.
Sara FriedmanAlbert Einstein College of Medicine, Bronx, NY, United States.
Risha SheniDepartment of Otorhinolaryngology-Head and Neck Surgery, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, United States.
Dana WatnickDepartment of Pediatrics, Albert Einstein College of Medicine, Bronx, NY, United States.
Della MakowerDepartment of Oncology, Montefiore Medical Center, Bronx, NY, United States.
Anjuli M GuptaDepartment of Surgery, Breast Surgery Division, Montefiore Medical Center, Bronx, NY, United States.
Sheldon FeldmanDepartment of Surgery, Breast Surgery Division, Montefiore Medical Center, Bronx, NY, United States.
Maureen McEvoyDepartment of Surgery, Breast Surgery Division, Montefiore Medical Center, Bronx, NY, United States.
Vikas MehtaDepartment of Otorhinolaryngology-Head and Neck Surgery, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Time to treatment initiation (TTI) delays result in worse cancer outcomes. Patients in under-resourced communities may experience TTI delays due to structural challenges and social determinants of health (SDOH), impacting access to timely care. We conducted a qualitative study in breast cancer patients with and without delayed TTI from an under-served community to explore barriers and facilitators to TTI from the patient perspective. Methods: We interviewed 30 patients who received curative intent breast cancer treatment at Montefiore Medical Center from 2019 to 2024. Half of the patients had delayed TTI (≥45 days), while the other half were not delayed. Interviews addressed barriers and facilitators of timely TTI, perceived timeliness of care, emotional well-being, and perceptions of the healthcare team and communication. Interviews were coded based on recurring ideas and patterns, and framework analysis was used to finalize themes. Results: Our cohort (n=30) had a mean age of 60.9 years, all whom identified as female. Most participants identified as Black or African-American (56.7%), and 16.7% identified as Hispanic/Latino. Age, race, ethnicity, tumor stage, and first treatment modality were similar between delayed and non-delayed TTI groups, whereas the distribution of pathologic diagnoses approached borderline significance. The mean TTI in delayed participants was 55.1 days and 32.7 days in the non-delayed group. Three main themes were identified: (1) Facilitators and Barriers, (2) Coping in the Interim: Waiting for Treatment Initiation, and (3) Patient Perceptions of Timeliness. Delayed patients faced financial burdens, transportation issues, and childcare challenges, hindering ability to adhere to schedules. Approximately half of the full cohort (delayed and non-delayed patients) wished their treatment began sooner, while half of the delayed TTI group expressed preference for longer TTI that afforded them time to prepare for treatment, make important decisions and seek opinions. Frequently participants found significant emotional and logistical support through family, social networks, and religion as well. Conclusions: Our study revealed that delayed patients faced financial and logistical barriers to initiating treatment. Findings from our work highlight the need for healthcare systems to better equip and engage patients in the care timeline to avoid delayed TTI.

Indexed as

breast cancersocial determinants of healthsocial needstime to treatmenttreatment delay

Identifiers

PMID42688067
PMCPMC13533727

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.